7Baggers
Quarterly
Annual
    Unit: USD2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 
      
    		               
      assets
    		               
      current assets
    		               
      cash and cash equivalents
    		401,556,000 111,628,000 130,934,000 131,990,000 120,265,000 117,470,000 154,409,000 218,164,000 217,685,000 268,608,000 350,823,000     
      short-term investments
    		40,000,000 45,000,000       50,000,000 50,000,000      
      restricted cash
    		5,100,000 5,100,000 5,100,000 5,100,000 5,100,000 79,164,000 60,192,000 34,182,000 26,532,000 18,900,000      
      prepaid expenses
    		3,377,000 10,914,000 11,866,000 14,576,000 19,054,000 21,493,000 8,732,000 7,304,000 5,531,000 6,428,000 7,670,000 73,390 101,192 108,370 171,191 
      accounts and other receivables
    		21,104,000 7,912,000 8,375,000 5,103,000 10,127,000 20,190,000 24,920,000 20,992,000 11,199,000       
      total current assets
    		471,137,000 180,554,000 156,275,000 156,769,000 154,546,000 159,153,000 188,061,000 246,460,000 284,415,000 347,850,000 373,494,000 649,964 1,086,306 1,298,677 1,488,185 
      property, plant and equipment
    		2,421,000 2,756,000 3,150,000 3,553,000 4,116,000 4,632,000 5,237,000 4,506,000 4,770,000 4,972,000 5,325,000     
      in-process research and development
    		16,900,000 16,900,000 16,900,000 16,900,000 16,900,000 16,900,000 16,900,000 16,900,000 16,900,000 16,900,000 16,900,000     
      intangible assets
    		704,000 749,000 793,000 837,000 882,000 926,000 970,000 1,015,000 1,059,000 1,103,000 1,148,000     
      goodwill
    		8,255,000 8,255,000 8,255,000 8,255,000 8,255,000 8,255,000 8,255,000 8,255,000 8,255,000 8,255,000 8,255,000     
      long-lead material work in process
    		43,388,000 41,609,000 41,227,000 40,317,000 36,361,000 30,765,000          
      other assets
    		1,868,000 2,461,000 2,633,000 3,185,000 3,798,000 8,731,000 5,949,000 5,054,000 6,704,000 6,263,000 2,109,000     
      total assets
    		544,673,000 253,284,000 229,233,000 229,816,000 224,858,000 308,526,000 309,464,000 332,390,000 348,635,000 404,243,000 407,231,000 232,994,297 233,407,245 233,615,163 233,801,679 
      liabilities and equity
    		               
      current liabilities
    		               
      accounts payable and accrued expenses
    		47,947,000 17,897,000 19,098,000 45,851,000 44,925,000 35,880,000 28,072,000 43,738,000 27,951,000 31,910,000 24,135,000     
      accrued compensation
    		7,330,000 7,749,000 5,734,000 5,412,000 8,546,000 9,588,000 6,403,000 6,442,000 9,038,000 9,052,000 5,647,000     
      long-lead material liability
    		32,327,000 33,064,000 32,445,000 32,323,000 32,323,000           
      other accrued liabilities
    		1,356,000 1,848,000 1,540,000 1,518,000 1,664,000 1,515,000 1,672,000 1,511,000 1,568,000 1,459,000 657,000     
      deferred revenue
    		762,000 78,000 78,000 206,000 898,000 33,381,000 23,779,000 1,078,000 856,000 1,131,000 794,000     
      total current liabilities
    		89,722,000 80,558,000 58,817,000 85,104,000 87,458,000 81,483,000 36,147,000 51,691,000 38,557,000 42,421,000 30,439,000 5,055,965 345,022 355,612 103,721 
      warrant liabilities
    		 58,681,000 51,500,000 14,767,000 5,722,000 12,183,000 23,258,000 30,457,000 29,349,000 38,211,000 41,412,000     
      noncurrent liabilities
    		1,650,000   1,048,000 1,442,000 1,832,000 2,076,000 2,433,000 2,786,000 2,995,000 2,848,000     
      total liabilities
    		91,553,000 163,159,000 135,922,000 101,125,000 95,520,000 128,879,000 85,260,000 85,659,000 71,548,000 84,758,000 75,493,000 53,089,965 37,544,022 38,579,612 36,839,721 
      stockholders' equity
    		               
      class a common stock
    		12,000 10,000 9,000 9,000 8,000 8,000 7,000 7,000 7,000 5,000 4,000     
      class b common stock
    		15,000 15,000 15,000 15,000 15,000 15,000 16,000 16,000 16,000 18,000 18,000     
      additional paid-in capital
    		995,745,000 462,146,000 420,948,000 382,068,000 333,888,000 327,593,000 312,618,000 302,487,000 296,748,000 272,217,000 221,379,000    13,668,974 
      accumulated deficit
    		-377,077,000 -302,102,000 -284,643,000 -257,026,000 -240,454,000 -221,699,000 -202,577,000 -193,054,000 -182,092,000 -169,478,000 -158,771,000 -52,396,243 -36,437,352 -37,265,024 -8,669,940 
      total stockholders' equity excluding noncontrolling interests
    		618,695,000    93,457,000    114,679,000       
      noncontrolling interests
    		-165,575,000 -69,944,000 -43,018,000 3,625,000 35,881,000 73,730,000 114,140,000 137,275,000 162,408,000 216,723,000 269,108,000     
      total stockholders' equity
    		453,120,000 90,125,000 93,311,000 128,691,000 129,338,000 179,647,000 224,204,000 246,731,000 277,087,000 319,485,000 331,738,000     
      total liabilities and stockholders' equity
    		544,673,000 253,284,000 229,233,000 229,816,000 224,858,000 308,526,000 309,464,000 332,390,000        
      customer deposit
    		 20,000,000              
      noncurrent accounts payable and accrued expenses
    		 23,604,000 24,880,000             
      other noncurrent liabilities
    		 238,000 647,000             
      stockholders’ equity
    		               
      total stockholders’ equity excluding noncontrolling interests
    		 160,069,000 136,329,000 125,066,000  105,917,000 110,064,000 109,456,000  102,762,000 62,630,000     
      cfpp liability
    		     34,500,000          
      long-term contract work in process
    		      23,900,000 16,018,000        
      convertible note payable
    		               
      mezzanine equity
    		               
      convertible preferred units
    		               
      common units
    		               
      total liabilities, mezzanine equity and stockholders' equity
    		        348,635,000 404,243,000 407,231,000     
      accounts receivable
    		         22,814,000 15,001,000     
      convertible notes payable
    		               
      ​
    		               
      current assets:
    		               
      cash
    		           576,574 985,114 1,190,307 1,316,994 
      investments held in trust account
    		           232,344,333 232,320,939  232,313,494 
      liabilities, class a ordinary shares subject to possible redemption and shareholders' deficit:
    		               
      current liabilities:
    		               
      accounts payable
    		           109,931 305,022 345,062 21,438 
      accrued expenses
    		           4,946,034 40,000 10,550 82,283 
      derivative warrant liabilities
    		           39,984,000 29,149,000 30,174,000 28,686,000 
      deferred underwriting fee payable
    		           8,050,000 8,050,000   
      commitments and contingencies
    		               
      class a ordinary shares subject to possible redemption, 0.0001 par value; 23,000,000 shares at redemption value of 10.10 per share
    		           232,300,000 232,300,000   
      shareholders' deficit:
    		               
      preference shares, 0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
    		               
      class a ordinary shares, 0.0001 par value; 300,000,000 shares authorized; no non-redeemable shares issued or outstanding
    		               
      class b ordinary shares, 0.0001 par value; 30,000,000 shares authorized; 5,750,000 shares issued and outstanding
    		           575 575   
      total shareholders' deficit
    		           -52,395,668 -36,436,777 -37,264,449  
      total liabilities, class a ordinary shares subject to possible redemption and shareholders' deficit
    		           232,994,297 233,407,245   
      preference shares, 0.0001 par value; 1,000,000 shares authorized; none issued and outstanding
    		               
      investments held in brokerage account
    		             232,316,486  
      liabilities and shareholders' deficit
    		               
      deferred underwriting fees payable
    		             8,050,000 8,050,000 
      class a ordinary shares subject to possible redemption, 23,000,000 shares at 10.10 redemption value as of september 30, 2021 and december 31, 2020 respectively
    		             232,300,000  
      shareholders' deficit
    		               
      class a ordinary shares, 0.0001 par value; 300,000,000 shares authorized; no shares issued and outstanding as of september 30, 2021 and december 31, 2020
    		               
      class b ordinary shares, 0.0001 par value; 30,000,000 shares authorized; 5,750,000 shares issued and outstanding as of september 30, 2021 and december 30, 2020
    		             575  
      total liabilities and shareholders' deficit
    		             233,615,163  
      liabilities and shareholders' equity
    		               
      ordinary shares subject to possible redemption, 19,006,134 and 18,582,720 shares issued and outstanding as of june 30, 2021 and december 31, 2020 shares at redemption value as of june 30, 2021 and december 31, 2020, respectively
    		              191,961,950 
      shareholders' equity:
    		               
      preference shares, 0.0001 par value; 1,000,000 shares authorized; none issued and outstanding as of june 30, 2021 and december 31, 2020
    		               
      class a ordinary shares, 0.0001 par value; 300,000,000 shares authorized; 3,993,866 and 4,417,280 issued and outstanding as of june 30, 2021 and december 31, 2020, respectively.
    		              399 
      class b ordinary shares, 0.0001 par value; 30,000,000 shares authorized; 5,750,000 issued and outstanding as of june 30, 2021 and december 31, 2020
    		              575 
      total shareholders' equity
    		              5,000,008 
      total liabilities and shareholders' equity
    		              233,801,679 
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.